To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1,977.00a day ago
2,091.00a day ago
arrow

LOWER/UPPER CIRCUITS

1,653.20
2,479.60
arrow
Caplin Point Laboratories Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 15.49%, in the last year to ₹2,033.9 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 17.33% in the last year to ₹536.31 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 28.18, lower than its sector PE ratio of 43.86.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 26.77%
Net profit growth 5Y CAGR : 21.17%
Caplin Point Laboratories Ltd Top mutual funds holding
arrow
Caplin Point Laboratories was established in 1990 to manufacture a range of ointments, creams and other external applications. It is the mid-sized company in India’s pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility.
personal

Grow your wealth with more research recommendations

+91